Long-term persistence and effectiveness of IL-12/23 pathway inhibitor ustekinumab and TNF inhibitors Annals of the Rheumatic Diseases 5:31 1 year ago 153 Скачать Далее
Persistence and effectiveness of the IL-12/23 pathway inhibitor ustekinumab Annals of the Rheumatic Diseases 5:17 2 years ago 203 Скачать Далее
IBDClub |June 2023| Vedolizumab vs. Ustekinumab in Crohn's Disease IBD CLUB 13:19 1 year ago 292 Скачать Далее
JAK inhibition in rheumatoid arthritis paradigm shift or just more tools - Gerd Burmester Societatea Romana de Reumatologie 29:33 3 years ago 158 Скачать Далее
UEGW 2021 - New Janssen Data Demonstrates Long-Term Safety of STELARA in Older IBD Patients HPR 7:05 2 years ago 311 Скачать Далее
Reducing Anti-TNF Dose Possible in Rheumatoid Diseases MDedge: news and insights for busy physicians 2:37 12 years ago 446 Скачать Далее
Wicks I (2014): Cytokine signalling in rheumatoid arthritis (G-CSF/GM-CSF/IL-17) WEHI Seminars 59:31 9 years ago 1 880 Скачать Далее
Advances in Anti Cytokine Therapy: Mechanisms of Action and Efficacy HMP Education 16:00 3 years ago 802 Скачать Далее
Psoriasis Treatment Update: A Focus on Targeted Therapies HMP Education 45:05 2 years ago 1 037 Скачать Далее
Back to Basics – Examining Mechanisms of New IBD Therapies CME Outfitters 1:32:09 1 year ago 466 Скачать Далее
G-ECHO Fellows presentation : Advanced drugs in IBD Gastro Foundation 52:27 8 months ago 424 Скачать Далее
IOA Orthopaedic Rheumatology 2023 Ortho TV : Orthopaedic Video Channel 2:23:41 Streamed 1 year ago 1 701 Скачать Далее
What Are the Effects of Jakafi® (ruxolitinib) in Clinical Trials? JAKAFI ruxolitinib 8:54 2 years ago 607 Скачать Далее
